In vivo Characteristics of Thaw Siphon Cryoprecipitate Compared to Other Factor VIII Preparations

Summary

5 severe haemophiliacs were infused with cryoprecipitate prepared by the continuous thaw-siphon technique, with cryoprecipitate prepared by overnight thawing and with intermediate-purity factor VIII concentrate. All 3 preparations gave a similar mean half-life for coagulant factor VIII of approximately 10 hours. The immediate recovery of this activity was similar for the 2 cryoprecipitates, but higher for the purified concentrate.

Keywords

Cryoprecipitate - Factor VIII concentrate - Haemophilia

• References

• 1 Nilsson IM, Hedner U. Characteristics of various factor VIII concentrates used in treatment of Haemophilia A. Br J Haematol 1977; 37: 543-557
• 2 Smith JK, Bidwell E. Therapeutic materials used in the treatment of coagulation defects. Clin Haematol 1979; 8: 183-206
• 3 Pool JG, Shannon AE. Production of high potency concentrates of anti-haemophilic globulin in a closed bag system; assay in vitro and in vivo. N Engl J Med 1965; 273: 1443-1447
• 4 Johnson AJ, Karpatkin MH, Newman J. Preparation and clinical experience with anti-haemophilic factor concentrate. Thromb Diath Haemorrh 1969; suppl 35: 49
• 5 Mason EC. Thaw-siphon technique for production of cryoprecipitate concentrate for factor VIII. Lancet 1978; ii: 15-17
• 6 Prowse CV, McGill A. Evaluation of the "Mason" (continuous-thawsiphon) method for cryoprecipitate production. Vox Sang 1979; 37: 235-243
• 7 Prowse CV, Sas G, Gader AM A, Cort JH, Cash JD. Specificity in the factor VIII response to vasopressin infusion in man. Br J Haematol 1979; 41: 437-447
• 8 McFarlane EE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-308
• 9 Ellis BC, Stransky A. A quick and accurate method for the determination of fibrinogen in plasma. J Lab Clin Med 1961; 58: 477-488
• 10 Hardisty RM, Ingram GI C. Bleeding disorders: Investigation and management. Blackwell Scientific Publications Ltd., Oxford. 1965
• 11 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Ark Kemi 1956; 10: 415-426
• 12 Blatt PM, Brinkhous KM, Culp HR, Krauss JS, Roberts HR. Anti-haemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding time factor and ristocetin-cofactor activities. JAMA 1976; 236: 2770-2772
• 13 Allain JP, Verroust F, Soulier JP. 1 or 2-stage assay for factor VIII. Lancet. 1979; i: 1076-1077
• 14 Kirkwood TB L, Barrowcliffe TW. Discrepancy between 1-stage and 2-stage assays of factor VIII:C. Br J Haematol 1978; 40: 333-338
• 15 Mason EC, Harden PA, Shaw AE. The thaw-siphon procedure for cryoprecipitate production: an alternative pathway to an improved intermediate AHF concentrate within a closed pack system. Joint Congress of the International Society of Haematology and the International Society of Blood Transfusion, Paris 1978 Abstracts 1: p. 603